Category: Influenza
Global Influenza
-
Influenza Vaccines Global Market Report 2023 Including: 1) By Vaccine Type: Inactivated; Live Attenuated 2) By Valency: Quadrivalent; Trivalent 3) By Route Of Administration: Injection; Nasal Spray 4) By Age Group: Pediatric; Adult 5) By Distribution Channel: Hospitals And Pharmacies; Government And Institutional Supply Covering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Sanofi-Aventis LLC.
... Pharmacies; Government And Institutional SupplyCovering: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Sanofi-Aventis LLC. Influenza Vaccines Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Global Respiratory Syncytial Virus (RSV) Vaccine And Antibody Pipeline Market: Analysis By End User (Adult and Maternal & Pediatric), By Type (Vaccine & Antibody), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030
... up to 2030 RSV, or respiratory syncytial virus, is a common respiratory virus that causes mild, cold-like symptoms in both the upper and lower respiratory tracts. RSV can be harmful, especially in infants and the ... Read More
-
Global Influenza Vaccines Market, Persons Vaccinated, Key Company Analysis, Emerging Players Profile, Promising Influenza Vaccines in Clinical Development, Size, Share, Trends, Major Deals and Recent Developments - Forecast to 2030
... is projected to reach US$ 10.9 Billion by 2030. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The Centers for Disease Control and Prevention (CDC) recommends routine seasonal influenza vaccination ... Read More
-
Global Influenza Drugs Market Size study & Forecast, by Drug Type (Ribavirin, Oseltamivir, Relenza (Zanamivir), Peramivir, Influenza Vaccines), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel) and Regional Analysis, 2023-2030
... is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Influenza is a common viral infection that, ... Read More
-
Global Foot-and-Mouth Disease Virus Fluorescent Quantitative PCR Detection Kit Market Growth 2023-2029
... US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Foot-and-Mouth Disease Virus Fluorescent Quantitative PCR Detection Kit is forecast to a readjusted size ... Read More
-
Global Monkeypox Virus Real-Time PCR Kit Market Growth 2023-2029
... demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Monkeypox Virus Real-Time PCR Kit is forecast to a readjusted size of US$ million by 2029 with a CAGR of ... Read More
-
Global Influenza Vaccines Market - 2023-2030
... influenza vaccines market is expected to exhibit a CAGR of 6.9% during the forecast period (2023-2030). Influenza (flu) vaccinations (flu shots) are vaccines that protect against the four influenza viruses that are expected to be ... Read More
-
Global African Swine Fever Virus Detection Kit Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... size was valued at USD 1700.9 million in 2022 and is forecast to a readjusted size of USD 2578.6 million by 2029 with a CAGR of 6.1% during review period. The influence of COVID-19 and ... Read More
-
Global African Swine Fever Virus Detection Kit Supply, Demand and Key Producers, 2023-2029
... market growth of 6.1% CAGR during the forecast period (2023-2029). This report studies the global African Swine Fever Virus Detection Kit production, demand, key manufacturers, and key regions. This report is a detailed and comprehensive ... Read More
-
Global African Swine Fever Virus Detection Kit Market Growth 2023-2029
... 2029; it is expected to grow at a CAGR of 6.6% from 2023 to 2029. United States market for African Swine Fever Virus Detection Kit is estimated to increase from US$ million in 2022 to ... Read More
-
Influenza Vaccine Market Assessment, By Vaccine Type [Inactivated Influenza Vaccine, Live Attenuated Influenza Vaccine], By Type of Influenza [Seasonal and Pandemic], By Formulation [Trivalent, Quadrivalent], By Technology [Egg-based, Cell culture and Recombinant], By Age group [Paediatric and Adult], By Route of Administration [Intra-Muscular Injection, Nasal Spray], By Distribution Channel [Hospital, Retail Pharmacies, Government Suppliers and Others], By Region, By Opportunities and Forecast, 2016-2030F
... [Paediatric and Adult], By Route of Administration [Intra-Muscular Injection, Nasal Spray], By Distribution Channel [Hospital, Retail Pharmacies, Government Suppliers and Others], By Region, By Opportunities and Forecast, 2016-2030F Global Influenza Vaccine Market size was valued ... Read More
-
Global Seasonal Influenza Vaccine Market (2023 Edition): Analysis By Vaccine Type (Inactivated, Live Attenuated), Valency (Quadrivalent, Trivalent), Age Group, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)
... released a research report titled “Global Seasonal Influenza Vaccine Market (2023 Edition)” which provides a complete analysis of the Global Seasonal Influenza Vaccine industry in terms of market segmentation By Vaccine Type (Inactivated Influenza Vaccine ... Read More
-
Global Perinatal Infections Market Size Study & Forecast, by Infection Type (Cytomegalovirus Infection, Enterovirus Infection, Genital Herpes, Gonorrhoea, Human Immunodeficiency Virus, Others), By Diagnosis (Maternal Test, Neonatal Test, Others), By Treatment (Antibiotics, Antiviral, Antiretroviral, Others), By Route of Administration (Oral, Parenteral, Others), By End-user (Hospitals, Homecare, Specialty Clinics), and Regional Analysis, 2023-2030
... By Route of Administration (Oral, Parenteral, Others), By End-user (Hospitals, Homecare, Specialty Clinics), and Regional Analysis, 2023-2030 Global Perinatal Infections Market is valued at approximately USD XX billion in 2022 and is anticipated to grow ... Read More
-
Perinatal Infections Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Infection (Cytomegalovirus Infection, Enterovirus Infection, Genital Herpes, Gonorrhoea, Human Immunodeficiency Virus, Others); By Diagnosis (Maternal Test, Neonatal Test, Others); By Treatment (Antibiotics, Antiviral, Antiretroviral, Others); By Route of Administration (Oral, Parenteral, Others); By End User (Hospitals, Homecare, Specialty Clinics, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... By Treatment (Antibiotics, Antiviral, Antiretroviral, Others); By Route of Administration (Oral, Parenteral, Others); By End User (Hospitals, Homecare, Specialty Clinics, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) Global ... Read More
-
Isothermal Nucleic Acid Amplification Technology Market by Product (Assay, System), Technology (LAMP, SDA, NASBA, NEAR, HDA), Application (Diagnostics (Influenza, Hepatitis, CT/NG, COVID-19), blood screening), End User & Region - Global Forecast to 2028
... nucleic acid amplification technology market is projected to reach USD 6.8 Billion by 2028 from USD 4.4 Billion in 2023, at a CAGR of 9.2% during the forecast period. Increasing prevalence of infectious diseases, launches ... Read More
-
Global Monkeypox Virus Real Time PCR Test Kit Market Growth 2023-2029
... Monkeypox Virus Real Time PCR Test Kit sales in 2022, providing a comprehensive analysis by region and market sector of projected Monkeypox Virus Real Time PCR Test Kit sales for 2023 through 2029. With Monkeypox ... Read More
-
Gene Vector Market (Vector Type: Lentivirus, Adenovirus, Adeno-associated Virus (AAV), Plasmid DNA, and Others, Disease: Genetic Disorder, Cancer, Infectious Disease, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-
... Market – Scope of Report TMR’s report on the global gene vector market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Influenza A Virus, H7N9 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H7N9 Subtype Infections - Drugs In Development, 2022, provides an overview of the Influenza ... Read More
-
Influenza Vaccine Market Forecasts to 2028 – Global Analysis By Vaccine Type (Trivalent and Quadrivalent), Type (Pandemic, Seasonal and Other Types), Technology (Egg-Based and Cell-Based), Age Group, Route of Administration, Distribution Channel and By Geography
... According to Stratistics MRC, the Global Influenza Vaccine Market is accounted for $8.11 billion in 2022 and is expected to reach $19.34 billion by 2028 growing at a CAGR of 15.58% during the forecast period. ... Read More
-
Global Remote Patient Monitoring Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 By Component Type (Devices, and Software & Services), Product (Vital Sign Monitors, and Special Monitors), Application (Cancer, Cardiovascular Diseases(CVD), Diabetes, Sleep Disorder, Weight management & Fitness Monitoring, Bronchitis, Infections, Virus, Dehydration, and Hypertension), End-User (Hospitals & Clinics, Home Care Settings & Long Term Care Centre’s, Ambulatory Care Centre’s, Passive Exoskeletons, Payers, and Patients) and Region (North America, Europe, Asia Pacific, Latin America Middle East, and Africa (LAMEA))
... management & Fitness Monitoring, Bronchitis, Infections, Virus, Dehydration, and Hypertension), End-User (Hospitals & Clinics, Home Care Settings & Long Term Care Centre’s, Ambulatory Care Centre’s, Passive Exoskeletons, Payers, and Patients) and Region (North America, Europe, ... Read More
-
Global Pediatric Vaccines Market By Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines), By Indication (Varicella, Diphtheria, Pertussis and Tetanus, Influenza, Human Papilloma Virus, Measles, Mumps and Rubella, Meningococcal Disease, Pneumococcal Disease, Polio, Rotavirus, Other Indications): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Mumps and Rubella, Meningococcal Disease, Pneumococcal Disease, Polio, Rotavirus, Other Indications): Global Opportunity Analysis and Industry Forecast, 2021-2031 The global pediatric vaccine market accounted for $2,1371.73 million in 2021, and is expected to reach $ ... Read More
-
Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly)
... Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly) The influenza vaccines market is expected to grow from US$ 7,478.53 million in 2021 to US$ 12,272.49 million by 2028. ... Read More
-
Global Flu Vaccine Market - 2022-2029
... during the forecast period (2022-2029). The flu vaccine is inactivated, indicating that it includes the killed influenza virus, or a recombinant vaccine, implying that it was made without exploiting virus particles. Flue vaccination is safe ... Read More
-
Global Digital Vaccine Market By Device Used (Smartphones, Tablets, Others), By Application (COVID-19, Influenza, Diabetes, Cardiovascular Diseases, Hypertension, Others), and By Region, Competition Forecast and Opportunities, 2027
... observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of life-related diseases such as chronic diseases, cardiovascular diseases, infectious diseases, and others, and extensive developments in technology, which are driving ... Read More
-
Glycomic Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Class (Isolated and Synthetic), Structures [Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins & Heparin Based Glycans, Targeting Glycosphingolipids, and Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate; Erythropoietin & Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 & 3; Beta & Gamma Interferons; and Others]
... Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins ... Read More
Research Assistance
